Arambala, Judith .
HRN: 25-53-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2024
CEFUROXIME 1.5GM (VIAL)
08/13/2024
08/13/2024
IV
1.5g
Ptor
For Elective Diagnostic D&C
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes